141,900 Shares in Kenvue Inc. $KVUE Bought by Cohen Capital Management Inc.

Cohen Capital Management Inc. purchased a new stake in shares of Kenvue Inc. (NYSE:KVUE) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 141,900 shares of the company’s stock, valued at approximately $2,448,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Salomon & Ludwin LLC purchased a new stake in shares of Kenvue during the 3rd quarter worth about $25,000. NBT Bank N A NY increased its stake in shares of Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after purchasing an additional 1,006 shares in the last quarter. Cornerstone Planning Group LLC increased its stake in shares of Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after purchasing an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC raised its holdings in Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares during the period. Finally, Trust Co. of Vermont raised its holdings in Kenvue by 50.9% in the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Price Performance

Shares of NYSE KVUE opened at $17.16 on Friday. The firm has a 50-day simple moving average of $17.98 and a 200-day simple moving average of $17.08. The stock has a market capitalization of $32.90 billion, a price-to-earnings ratio of 22.29, a price-to-earnings-growth ratio of 3.89 and a beta of 0.61. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same period in the previous year, the business posted $0.26 earnings per share. Kenvue’s quarterly revenue was up 3.2% on a year-over-year basis. On average, equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. The ex-dividend date was Wednesday, February 11th. Kenvue’s payout ratio is currently 107.79%.

Analysts Set New Price Targets

Several brokerages have commented on KVUE. Canaccord Genuity Group raised their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Barclays upped their target price on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Friday, March 6th. Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and decreased their target price for the company from $23.00 to $18.00 in a research report on Friday, January 30th. UBS Group lifted their price target on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Finally, Citigroup boosted their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Three equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $19.58.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.